Paige
Company

Last deal

$125M

Amount

Series C

Stage

14.01.2021

Date

3

all rounds

$220M

Total amount

date founded

Financing round

General

About Company
Paige develops computational pathology products for informed treatment decisions.

Industry

Sector :

Subsector :

founded date

01.02.2018

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

Paige created a platform that improves efficiency and accuracy for pathologists, providing data for precise diagnoses. They received FDA breakthrough designation and have a team of experts in pathology, machine learning, healthcare, and business. Paige's platform includes a viewer for primary diagnosis, scalable storage, and compatibility with other digital pathology solutions. They offer software solutions for prostate biopsy diagnosis and breast cancer detection. Additionally, Paige helps life sciences companies with biomarker discovery and clinical trial design.
Contacts

Contact Email

Social url

Similar Companies
1000
PathAI

PathAI

PathAI uses AI-powered technology to provide reliable, scalable, and cost-effective solutions for rapid and accurate diagnoses.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Boston, MA, USA

total rounds

6

total raised

$351M
Solvemed Group

Solvemed Group

Solvemed Group is a neuroscience artificial intelligence company that redefines patient care and drug discovery.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Artificial Intelligence, Biotechnology

Location

Cambridge, UK

total rounds

2

total raised

$4.4M
Omniscope

Omniscope

Omniscope is a Deep Biotech that decodes the immune system using high-resolution sequencing and AI.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Barcelona, Spain

total rounds

7

total raised

$7.92M
OncoAssign

OncoAssign

Oncoassign is an AI-powered precision oncology start-up that predicts accurate cancer treatments.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Financials

Funding Rounds
5
3

Number of Funding Rounds

$220M

Money Raised

Their latest funding was raised on 14.01.2021. Their latest investor Healthcare Venture Partners. Their latest round Series C

Johnson & Johnson Innovation – JJDC

Johnson & Johnson Innovation – JJDC

JJDC helps innovative healthcare ideas become real solutions for patients.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care

Location

Cambridge, MA, USA

count Of Investments

79

count Of Exists

3
Casdin Capital

Casdin Capital

Casdin Capital is an investment firm that specializes in the life sciences and healthcare industry.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Finance

Location

New York, NY, USA

count Of Investments

170

count Of Exists

13
KKR Real Estate Finance Trust

KKR Real Estate Finance Trust

KKR Real Estate Finance Trust is a real estate finance company.

Sector

Finance and Credit Services

Subsector

Mortgage Finance

Location

New York, NY, USA

count Of Investments

2
Goldman Sachs Merchant Banking Division

Goldman Sachs Merchant Banking Division

Goldman Sachs Merchant Banking Division is a private equity and venture capital firm that provides equity and credit investment.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Location

New York, NY, USA

count Of Investments

21

count Of Exists

6
Goldman Sachs Merchant Banking Division

Goldman Sachs Merchant Banking Division

Goldman Sachs Merchant Banking Division is a private equity and venture capital firm that provides equity and credit investment.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Location

New York, NY, USA

count Of Investments

21

count Of Exists

6
Co-Investors
Investors
8
6

Number of lead investors

8

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Series B, Series C
No
Series B
Yes
Series A, Series B

Healthcare Venture Partners

Healthcare & Life Sciences Investment Firm focused on investing in companies in the healthcare and life sciences sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Charleston, SC, USA

count Of Investments

3
Kenan Turnacioglu

Kenan Turnacioglu

Kenan Turnacioglu is a General Partner & Member of the Investment Committee at Catalio Capital Management. He is also the Chairman of PaigeAI, a machine learning pathology company spun out of Memorial Sloan Kettering. In 2011, Kenan co-founded PointState Capital, LP and managed the portfolios and investment teams in Healthcare and Consumer sectors, before departing in 2018. From 2001 to 2010, he worked at Duquesne Capital Management, LLC managing Healthcare investments. While at these positions he also served on the Boards of StemCentrx (2013-2016), Agensys (2004-2007), and NYU Langone Cancer Center (2010-2015). From 1998-2000, he worked at Credit Suisse as an analyst on the biotech team.

current job

Catalio Capital Management
Catalio Capital Management

count Of Investments

3
Breyer Capital

Breyer Capital

Breyer Capital is a global venture capital and private equity investor that catalyzes high-impact entrepreneurs.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Artificial Intelligence

Location

Menlo Park, CA, USA

count Of Investments

124

count Of Exists

7
Jim Breyer

Jim Breyer

Mr. James Breyer serves as a Board Member at MSD Acquisition. He serves as Board Member at Blackstone. He served as a Board Member at Atropos Health. He serves as Board Member at Blackstone. He is a Co-Owner of the Boston Celtics. He serves as an Investment Advisory Board Member at Xfund. He serves as an Advisor at Vida. He is a Co-Founder and Board Member of EDO and a Board Member of GNL Québec. He served as a Board Member at UM and Wickr. He previously served as Co-Chairman at IDG Capital. He has been an investor in over 40 consumer internet/technology companies that have completed successful public offerings or mergers, including Facebook, Etsy, Legendary, Datalogix, and Marvel Entertainment. As a lead investor and/or board member, he has assisted teams at over a dozen companies in complete IPOs. Several of his investments have returned to investors over 100 times their cost and over a dozen more have returned over 25 times cost. Over the past several years, he has developed a deep personal and investment interest in long-term oriented entrepreneurs and teams working in artificial intelligence (AI) and human-assisted intelligence (HAI) and he has made numerous investments in this space. He is Chairman of the Compensation Committee and a member of the Nominating Committee. He served on Facebook's board from 2005 to 2013 after leading the company's Series A funding round. He served on Etsy's board from 2008 to 2016 and was the company's largest outside shareholder during its IPO in 2015. Notably, Etsy is one of the first B Corporations to successfully go public and continue to grow significantly post-offering. He was the lead investor for Legendary Entertainment's first funding round and served as a board member until its acquisition by Dalian Wanda in March 2016. He was also an investor and board member of Marvel Entertainment through its investment by Disney in 2009. His other board memberships include Wal-Mart, where he served for over a decade and was the lead independent director until his retirement in 2013, and Dell Inc., where he was a director through the company's $24 billion take-private in 2013. He is passionate about philanthropy and applying venture philanthropy and innovation models to education, the arts, and environmental sustainability. He is a Fellow of Harvard Corporation, Harvard's senior governing board; a member of Harvard Business School's Board of Dean's Advisors since 2001; a member of Harvard University's Global Advisory Council since inception; a founding member of the Dean's Advisory Board at Stanford's School of Engineering. He is passionate about the Breyer Center at Stanford-in-Florence and is a former Trustee of Menlo School (a grade 6-12 school in Atherton, CA). In addition, he is a long-time Trustee of SFMOMA, The Metropolitan Museum of Art in New York, and the American Film Institute (AFI) in Los Angeles. He is actively involved in The Environmental Defense Fund and Stanford's Center for Philanthropy and Civil Society (PACS). He began his career at Accel, where he was a partner for nearly three decades and served as Managing Partner. He also co-founded AKKR, a joint venture between Accel and KKR in 2000. He graduated from Stanford University with a BS degree, and from Harvard University with an MBA, where he was named a Baker Scholar. He is also an Angel Investor. He is a Co-Founder and served as a Board Member at Accel-KKR. He serves as an Advisor at Elemental Cognition. He serves as an Advisor at ClosedLoop.ai. [Source: Public Company Filing]

current job

Breyer Capital
Breyer Capital

organization founded

4

People

Founders
5
Peter Schüffler
Peter Schüffler

Peter Schüffler

organization founded

1

Peter Schüffler

David Klimstra
David Klimstra

David Klimstra

David Klimstra is Director Pathology at Paige.AI. David is an Alumni Chair of the Department of Pathology at Memorial Sloan Kettering Cancer Center. He is a surgical pathologist with nearly 30 years of broad diagnostic experience. Internationally recognized author and translational researcher, with a dedication to the evaluation and implementation of novel diagnostic technologies in pathology laboratories.

organization founded

1

David Klimstra

Peter Schüffler
Peter Schüffler

Peter Schüffler

Peter Schüffler is the Assistant Professor at TUM. Peter Schüffler attended ETH Zürich.

current job

Paige
Paige

organization founded

1

Peter Schüffler

Thomas Fuchs
Thomas Fuchs

Thomas Fuchs

Thomas Fuchs is Founder & Chief Science Officer at Paige. He is Director of Computational Pathology Lab at Memorial Sloan Kettering Cancer Center and professor for Machine Learning at Weill Cornell. Former research technologist at NASA's Jet Propulsion Laboratory in Pasadena. Postdoctoral research focus in computer vision, medical imaging at Caltech. PhD in Machine Learning from ETH Zurich.

current job

Paige
Paige

organization founded

1

Thomas Fuchs

Employee Profiles
10
Asish Xavier

Asish Xavier

Member Board Of Directors

Carla Leibowitz

Carla Leibowitz

Chief Business Development Officer

Jason Locke

Principal of user experience

Quynh Nguyen

Business office manager

Leo Grady

Leo Grady

CEO

Peter Schüffler

Peter Schüffler

Co-Founder & Senior Machine Learning Scientist

Leo Grady

Chief executive officer

Thomas Fuchs

Thomas Fuchs

Founder & Chief Scientific Officer

Activity

Recent News
6
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week